Chemistry and Physics Faculty Articles

ORCID

0000-0002-7622-3986

ResearcherID

CFW-8633-2022

Document Type

Article

Publication Title

Biomedical Journal of Scientific & Technical Research

ISSN

2574-1241

Publication Date

11-5-2018

Abstract

Human Immunodeficiency Virus (HIV) continues to be a major global public health issue. Inhibition of HIV envelope fusion with the CD4 cell membrane prevents the entry of HIV into the CD4 cells providing a novel approach to the treatment of HIV infection. Thus, interference in the fusion of the virus with the co-receptor substrate appears to be a specific and potential way to fight HIV infection and replication. Applications of click chemistry are spreading in the field of drug discovery and it became a powerful tool for the synthesis of medicinally important compounds.

Remarkably, the Cu (I)-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) click chemistry has become a superior approach for the synthesis of privileged medicinal skeletons in the discovery of anti-HIV agents. Click reactions got enormous popularity because of a high degree of reliability, complete specificity (chemoselectivity and regioselectivity) and it employs chemical reactions that are wide in scope, of high yielding and produce very little or no by-products. In this review, we outlined current approaches towards the development of peptide based HIV fusion inhibitors employing click chemistry.

DOI

10.26717/BJSTR.2018.10.002004

Volume

10

Issue

5

First Page

8054

Last Page

8058

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Peer Reviewed

Included in

Chemistry Commons

Share

COinS